News Details

Jan 20, 2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | Announcements and Notices    read more...
Jan 20, 2025
CHANGE IN COMPOSITION OF NOMINATING AND CORPORATE GOVERNANCE COMMITTEE AND RE-COMPLIANCE WITH RULE 3.27A OF THE LISTING RULES | Announcements and Notices    read more...
Jan 17, 2025
RECORD DATE FOR EXTRAORDINARY GENERAL MEETING | Announcements and Notices    read more...
Jan 13, 2025
INSIDE INFORMATION - BUSINESS UPDATE | Announcements and Notices    read more...
Jan 08, 2025
OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-K/A | Announcements and Notices    read more...
Jan 08, 2025
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Jan 07, 2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 | Monthly Returns    read more...
Jan 06, 2025
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | Announcements and Notices    read more...
Jan 06, 2025
BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe    read more...
Jan 02, 2025
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Dec 30, 2024
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Dec 27, 2024
TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy | RegularNews    read more...
Dec 23, 2024
CHANGE OF NASDAQ TICKER SYMBOL | Announcements and Notices    read more...
Dec 23, 2024
BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference | RegularNews    read more...
Dec 16, 2024
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Dec 12, 2024
BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor | RegularNews    read more...
Dec 12, 2024
BeiGene Unveils Breast Cancer Pipeline    read more...
Dec 11, 2024
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Dec 10, 2024
OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K | Announcements and Notices    read more...
Dec 09, 2024
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets | RegularNews    read more...